Advanced search×

Sialoglycotherapeutics in protozoal diseases.

Mini Rev Med Chem 8(4):358-69 (2008) PMID 18473927

The manipulation of glycosylation, mainly sialylation, holds enormous potential for understanding the biological functions of glycoproteins and glycolipids to treat many diseases. The existing knowledge in the field of glycobiology is exploited by glycotherapeutics for combating protozoan diseases. This review focuses on the development of novel glycobiological therapeutic strategies in the field of protozoan infections.

Version: za2963e q8za5 q8zbd q8zcd q8zdf q8ze2 q8zf4 q8zgb

Similar articles you may find interesting…

  1. Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmani...

    Glycoconj J 26(6):675-89 (2009) PMID 19184417

    We report the discovery and characterization of a glycosylated bacterial ABC-type phosphate transporter isolated from the peripheral blood mononuclear cell (PBMC) fraction of patients with visceral leishmaniasis (VL). Three disease-associated 9-O-acetylated sialoglycoproteins (9-O-AcSGPs) of 19, 56...